Recon: Pfizer publishes promising RSV data ahead of FDA decision; DOJ charges 3 former Magellan execs with selling defective lead tests
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy